About Addition Therapeutics
Addition Therapeutics develops genetic medicines using its proprietary PRINT technology. This technology combines RNA therapeutics and gene therapies to deliver functional cures for patients with severe lifelong diseases. The company focuses on rare patient populations and aims to address larger related patient populations.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Venture Round
Global Headquarters
South San Francisco, United States
Year Founded
2021
Team Size
11-50
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
additiontx.com
Domain Registered Date
May 25, 2021
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $100,000,000 · Venture Round
Pulse 2.0
- Milestone
Website domain registered
additiontx.com
- Milestone
Company founded
South San Francisco, United States
Investors & Backers
Abingworth
BEVC
Bill & Melinda Gates Foundation
OUP (Osage University Partners)
Pivotal Life Sciences
SR One
Funding History
Venture Round
· Dec 17, 2025
$100,000,000 Pulse 2.0
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026